Lanfan Medical: Announcement on the progress of the company's application for credit from banks to provide guarantees
Securities code: 002382 Securities abbreviation: Lanfan Medical Announcement number: 2026-062
Blue Sail Medical Co., Ltd.
Announcement on the progress of the company's application for credit from banks to provide guarantees
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
1. Overview of guarantee situation
Lansail Medical Co., Ltd. (hereinafter referred to as the "Company" or "Lansan Medical") held the 35th meeting of the sixth board of directors on December 12, 2025, and the seventh extraordinary shareholders' meeting of 2025 on December 29, 2025. The "Proposal on Application for Credit and Guarantee Amount Estimation in 2026" was reviewed and approved. The company and its subsidiaries in 2026 Du plans to apply for a comprehensive credit extension of no more than RMB 3 billion from banks and other financial institutions. Credit extension types include but are not limited to working capital loans, letters of guarantee, bank acceptance bills, domestic letters of credit, domestic factoring, financial leasing and other comprehensive credit extension businesses (specific business types are subject to approval by relevant financial institutions). The specific financing amount will be determined based on the capital needs for the production and operation of the company and its subsidiaries. The company and its subsidiaries will provide guarantees for the above-mentioned comprehensive credit according to the credit requirements of financial institutions, with a total amount of guarantees not exceeding RMB 3 billion. The guarantee methods include but are not limited to joint liability guarantees, equity pledges, asset mortgages, credit guarantees, guarantee guarantees, etc. Among them, the guarantee amount provided to the company and its subsidiaries with an asset-liability ratio of less than 70% (exclusive) is expected to be no more than RMB 2.8 billion, and the guarantee amount provided to subsidiaries with an asset-liability ratio of more than 70% (inclusive) is expected to be no more than RMB 200 million. The above guarantee limit includes new guarantees and extensions or renewals of original guarantees. The guarantee limit is valid for 12 months from the date of passing the resolution of the shareholders meeting to review the proposal.
For details of the above content, please see the company's publications in "China Securities Journal" and "China Securities Journal" on December 13, 2025 and December 30, 2025 respectively. The "Announcement on the Estimated Application for Credit and Guarantee Amount in 2026" (Announcement No.: 2025-104) and the "Announcement on the Resolution of the Seventh Extraordinary Shareholders Meeting in 2025" (Announcement No.: 2025-115) were published on "Shanghai Securities News", "Securities Times", "Securities Daily" and cninfo.com (www.cninfo.com.cn).
2. Progress of Guarantee
In 2023, in order to meet the capital needs in production and operations, the company applied for credit from the Zibo Linzi Branch of Agricultural Bank of China Co., Ltd. (hereinafter referred to as "Agricultural Bank"). The loan amount is RMB 50 million and the loan term is 3 years. The company and its subsidiary Shandong Lan Fan New Materials Co., Ltd. (hereinafter referred to as "Shandong New Materials") and the Agricultural Bank of China signed the "Maximum Mortgage Contract" and the "Guarantee Contract" respectively. The subsidiary Shandong New Materials provided guarantee for the loan. At the same time, the company provided guarantee for the loan by mortgaging land and factory buildings. Subsequently, according to the business plan, the company changed the collateral under the above guarantee with the land and above-ground buildings under the name of its subsidiary Zibo Lanfan New Materials Co., Ltd. For details, please refer to the "Announcement on the Progress of the Company's Application for Credit Facility and Guarantee from Banks" (Announcement Number: 2023-010) and "Announcement on Changes in Guaranteed Collateral" (Announcement Number: 2023-054) disclosed by the company on March 1, 2023 and August 31, 2023 respectively.
Recently, in order to meet the capital needs in production and operation, the company re-applied to the Agricultural Bank of China for a credit of 40 million yuan, with a loan period of 1 year. Shandong New Materials signed a "Guarantee Contract" with the Agricultural Bank of China for this credit, providing joint and several liability for the credit that the company applied for this time. Guaranteed guarantee, the guaranteed guarantee amount is 40 million yuan; since the original "Maximum Mortgage Contract" is still valid, there is no need to sign a new contract for this credit extension, and the collateral is still the land and above-ground buildings under the name of the subsidiary Zibo Lanfan New Materials Co., Ltd.
The amount of this guarantee will not exceed the amount range of the credit and guarantee limit applied for by the company and its subsidiaries in 2026 as approved at the 35th meeting of the company's sixth board of directors and the seventh extraordinary shareholders' meeting in 2025. There is no need to convene a separate board of directors or shareholders' meeting for review.
As of the date of this announcement, the company's guarantee amount and usage within the scope approved by the seventh extraordinary shareholders' meeting in 2025 are as follows:
Unit: 10,000 yuan per load
Yes Guarantee This Guarantee New Guaranteed Party No Party Before This Guarantee After This Guarantee The Guaranteed Amount After
Guaranteed The most recent issue. Newly added secured parties this time. The secured party's remaining available party. The most insured party of the listed company. Assets and liabilities. Guaranteed amount. Joint share guarantee balance. Guaranteed balance. Guaranteed amount. Net rate in the latest period. Guarantee ratio. Asset ratio guaranteed.
Example
Shandong blue
Sail new materials
/
Materials are limited
Company Blue Sail
23.24% 52,318.29 4,000.00 56,318.29 242,095.99 0.56% No Zibo Lan Medical
Sail new materials
/
Materials are limited
company
Note: After this guarantee, the remaining available guarantee amount of the guaranteed party is the total guarantee available to the company and its subsidiaries with an asset-liability ratio of less than 70% (excluding 70%).
3. Basic information of the guaranteed person
Company name: Lanfan Medical Co., Ltd.
Unified social credit code: 91370000744521618L
Type: joint stock limited company (investment and listing in Hong Kong, Macao and Taiwan)
Legal representative: Liu Wenjing
Registered capital: RMB 1,007,129,138
Date of establishment: December 2, 2002
Residence: No. 48, Yinuo Road, Jixia Street, Linzi District, Zibo City, Shandong Province
Business period: December 2, 2002 to no fixed period
Business scope: production and processing of PVC gloves, nitrile gloves, Class I, II, and III medical devices, other plastic products, and pellets, and sales of products produced by the company; wholesale business of nitrile gloves, latex gloves, pulp molded products, and Class I and II medical device products. (Projects that require approval according to law can only carry out business activities after approval from relevant departments, and the validity period is subject to the license.)
Main financial data for the latest year and period:
Unit: RMB Serial Number Item December 31, 2025 March 31, 2026 1 Total assets 9,221,112,202.36 9,151,761,199.26 2 Total liabilities 2,159,992,240.72 2,126,734,916.91 3 Owners’ equity 7,061,119,961.64 7,025,026,282.35 4 Contingencies // Serial number Project 2025 January to March 2026
5 Operating income 149,202,235.36 35,558,061.23 6 Total profit -151,600,639.25 -36,175,366.78 7 Net profit -238,971,065.33 -36,175,366.78 Note: The above data is the data of Lanfan Medical alone, and the data on March 31, 2026 has not been audited.
- Credit situation: After checking the "China Enforcement Information Disclosure Network", Lanfan Medical Co., Ltd. is not a defaulter.
4. Main contents of the "Guarantee Contract"
Creditor: Agricultural Bank of China Co., Ltd. Zibo Linzi Branch
Guarantor: Shandong Lanfan New Materials Co., Ltd.
Guarantee amount: RMB 40 million
Scope of guarantee: The scope of guarantee includes the loan principal, interest, penalty interest, compound interest, liquidated damages, damages that the debtor should repay under the main contract, interest on delayed debt performance and delayed performance damages determined to be borne by the debtor and the guarantor in accordance with the relevant provisions of the "Civil Procedure Law of the People's Republic of China", preservation insurance premiums, litigation (arbitration) fees, lawyer's fees and other expenses for the creditor to realize its creditor's rights.
Guarantee method: joint liability guarantee
Guarantee period: three years from the expiration date of the debt performance period stipulated in the main contract
5. Cumulative number of external guarantees and number of overdue guarantees
As of the occurrence of this guarantee, the maximum guarantee amount of the company and its subsidiaries is RMB 2,866,000,900 (the balance of foreign currency guarantees are converted according to the exchange rate announced by the central bank on June 23, 2026), accounting for 40.00% of the company's audited net assets in 2025, and does not exceed 50% of the audited net assets in 2025. The total balance of guarantees provided by the company and its subsidiaries to units outside the consolidated statements is RMB 0.
The company and its subsidiaries have no overdue external guarantees, no external guarantees involving litigation, and no losses due to losses due to a judgment against the guarantee.
6. Documents for reference
"Guarantee Contract".
Announcement is hereby made.
Board of Directors of Lanfan Medical Co., Ltd.
June 24, 2026